Jonathan Richard Rice - 04 Dec 2024 Form 4 Insider Report for Kraig Biocraft Laboratories, Inc (KBLB)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Shares	Change %	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KBLB	Class A Common Stock Option	Exercise of in-the-money or at-the-money derivative security	+1,112,000	+35%	4,320,121	04 Dec 2024	Class A Common Stock	1,099,631	$0.0899	Direct	F1
transaction	KBLB	Class A Common Stock Options	Exercise of in-the-money or at-the-money derivative security	+181,518	+4.2%	4,499,698	15 Jan 2025	Class A Common Stock	179,576	$0.9350	Direct	F1
transaction	KBLB	Class A Common Stock Options	Exercise of in-the-money or at-the-money derivative security	+888,000	+20%	5,378,201	15 Jan 2025	Class A Common Stock	878,503	$0.9350	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The Reporting Person exercised the derivative security through a cashless exercise of stock options.